Literature DB >> 28630283

Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment.

Anna Moszczynska1, Sean Patrick Callan2.   

Abstract

Understanding the relationship between the molecular mechanisms underlying neurotoxicity of high-dose methamphetamine (METH) and related clinical manifestations is imperative for providing more effective treatments for human METH users. This article provides an overview of clinical manifestations of METH neurotoxicity to the central nervous system and neurobiology underlying the consequences of administration of neurotoxic METH doses, and discusses implications of METH neurotoxicity for treatment of human abusers of the drug.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28630283     DOI: 10.1124/jpet.116.238501

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  The Neuroprotective Effect of L-Stepholidine on Methamphetamine-Induced Memory Deficits in Mice.

Authors:  Mei Zhou; Xiaokang Gong; Qin Ru; Qi Xiong; Lin Chen; Yuanren Si; Huaqiao Xiao; Chaoying Li
Journal:  Neurotox Res       Date:  2019-06-14       Impact factor: 3.911

Review 2.  The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity.

Authors:  Manqing Wu; Hang Su; Min Zhao
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

Review 3.  The neurobiological mechanisms of physical exercise in methamphetamine addiction.

Authors:  António Pedro Delgado Morais; Inês Roque Pita; Carlos Alberto Fontes-Ribeiro; Frederico Costa Pereira
Journal:  CNS Neurosci Ther       Date:  2017-12-20       Impact factor: 5.243

4.  Astrocyte-derived TNF and glutamate critically modulate microglia activation by methamphetamine.

Authors:  Teresa Canedo; Camila Cabral Portugal; Renato Socodato; Tiago Oliveira Almeida; Ana Filipa Terceiro; Joana Bravo; Ana Isabel Silva; João Duarte Magalhães; Sónia Guerra-Gomes; João Filipe Oliveira; Nuno Sousa; Ana Magalhães; João Bettencourt Relvas; Teresa Summavielle
Journal:  Neuropsychopharmacology       Date:  2021-08-16       Impact factor: 7.853

5.  What Can We Learn from Animal Models to Study Schizophrenia?

Authors:  Fernanda Crunfli; Caroline Brandão-Teles; Giuliana S Zuccoli; Adriano J M Chaves Filho; Gabriela Maciel Vieira; Danyelle Silva-Amaral; José Alexandre Crippa; João F C Pedrazzi; Danielle S Macêdo; Elaine Del-Bel; Felipe V Gomes
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 6.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

Review 7.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

8.  Risks versus consequences of adolescent and young adult substance use: A focus on executive control.

Authors:  Monica Luciana
Journal:  Curr Addict Rep       Date:  2020-11-12

9.  Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.

Authors:  Mariana Cherner; Caitlin W-M Watson; Rowan Saloner; Laura E Halpin; Arpi Minassian; Sarah S Murray; Florin Vaida; Chad Bousman; Ian Everall
Journal:  Addict Behav       Date:  2019-06-12       Impact factor: 4.591

Review 10.  The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms.

Authors:  Lin Chen; Qin Ru; Qi Xiong; Mei Zhou; Kai Yue; Yuxiang Wu
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.